×
About 35,703 results

ALLMedicine™ Cardiomyopathy Center

Research & Reviews  13,039 results

Favorable outcomes after heart transplantation in Barth syndrome.
https://doi.org/10.1016/j.healun.2021.06.017
The Journal of Heart and Lung Transplantation : the Offic... Li Y, Godown J et. al.

Aug 1st, 2021 - Barth Syndrome (BTHS) is a rare, X-linked disease characterized by cardioskeletal myopathy and neutropenia. Comparative outcomes after heart transplantation have not been reported. We identified BTHS recipients across 3 registries (Pediatric Heart...

Takotsubo Cardiomyopathy After mRNA COVID-19 Vaccination.
https://doi.org/10.1016/j.hlc.2021.06.521
Heart, Lung & Circulation; Boscolo Berto M, Spano G et. al.

Aug 1st, 2021 - Takotsubo Cardiomyopathy After mRNA COVID-19 Vaccination.|2021|Boscolo Berto M,Spano G,Wagner B,Bernhard B,Häner J,|

Cardiac contractility modulation in patients with ischemic versus non-ischemic cardiomy...
https://doi.org/10.1016/j.ijcard.2021.07.048
International Journal of Cardiology; Fastner C, Yuecel G et. al.

Jul 31st, 2021 - Cardiac contractility modulation (CCM) is an FDA-approved device-based therapy for patients with systolic heart failure and normal QRS complex who are symptomatic despite optimal drug therapy. The purpose of this study was to compare the long-term...

see more →

Guidelines  19 results

2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary...
https://doi.org/10.1016/j.jtcvs.2021.04.052
The Journal of Thoracic and Cardiovascular Surgery; Bakaeen FG, Gaudino M et. al.

Jul 18th, 2021 - 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure.|2021|Bakaeen FG,Gaudino M,Whitman G,Doenst T,Ruel M,|

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic ca...
https://doi.org/10.1016/j.jtcvs.2021.04.001
The Journal of Thoracic and Cardiovascular Surgery; , Ommen SR et. al.

May 1st, 2021 - 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2021| ,Ommen SR,Mital S...

ACR Appropriateness Criteria® Nonischemic Myocardial Disease with Clinical Manifestatio...
https://doi.org/10.1016/j.jacr.2021.01.019
Journal of the American College of Radiology : JACR; , Rajiah P et. al.

Mar 3rd, 2021 - Nonischemic cardiomyopathies encompass a broad spectrum of myocardial disorders with mechanical or electrical dysfunction without evidence of ischemia. There are five broad variants of nonischemic cardiomyopathies; hypertrophic cardiomyopathy (Var...

Minimally Invasive Bilateral Stellate Ganglionectomy for Refractory Ventricular Tachyca...
https://doi.org/10.1016/j.jacep.2020.12.001
JACC. Clinical Electrophysiology; Elliott IA, DeJesus M et. al.

Jan 10th, 2021 - Cardiac sympathetic denervation (CSD) for refractory ventricular tachycardia (VT) has been shown to decrease VT recurrence and defibrillator shocks in patients with ischemic and nonischemic cardiomyopathy. Here and in the accompanying Video, we de...

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Ca...
https://doi.org/10.1016/j.jacc.2020.08.045
Journal of the American College of Cardiology; Ommen SR, Mital S et. al.

Nov 25th, 2020 - 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2020|Ommen SR,Mital S,B...

see more →

Drugs  62 results see all →

Clinicaltrials.gov  366 results

Clinical and Molecular Investigations Into Ciliopathies
https://clinicaltrials.gov/ct2/show/NCT00068224

Apr 30th, 2020 - Human diseases caused by defects of the primary cilium (ciliopathies) are a group of distinct disorders with overlapping features. Clinical features of ciliopathies include fibrocystic disease of the kidneys and liver, retinal degeneration, obesit...

Epidemiological Analysis for the Hereditary Transthytetin-related Amyloidosis (hATTR)
https://clinicaltrials.gov/ct2/show/NCT03237494

Apr 20th, 2020 - Hereditary TransThyRetin Amyloidosis (hATTR) is a slowly progressive condition, that is transmitted as an autosomal dominant trait and is characterized by abnormal extracellular deposits of fibrillar, misfolded proteins (amyloid fibrils) in the bo...

Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
https://clinicaltrials.gov/ct2/show/NCT03340675

Apr 7th, 2020 - This is a phase 2 randomized, double-blind, placebo-controlled, multiple dose study with an optional open-label extension to determine the safety, pharmacokinetics (PK) and efficacy of two doses of oral ifetroban in subjects with DMD. DMD patients...

Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001456

Mar 26th, 2020 - Hermansky-Pudlak Syndrome (HPS) is a rare autosomal recessive disease consisting of oculocutaneous albinism, a platelet storage pool defect and, in some patients, lysosomal accumulation of ceroid lipofuscin. Other manifestations include pulmonary ...

Arrhythmogenic Substrate in Primary Cardiomyopathies
https://clinicaltrials.gov/ct2/show/NCT03304847

Mar 26th, 2020 - The present study is designed as a prospective single center study. All selected patients with implanted ICD to prevent VT/VF recurrence who are referred to the Arrhythmology Department of San Donato Milanese Hospital, for the management of a prim...

see more →

News  769 results

The Sick-Quitter Effect: How Alcohol Can Seem Cardioprotective When It Isn't
https://www.medscape.com/viewarticle/953696

Jun 29th, 2021 - People ask me if they should drink more red wine. They ask me this repeatedly. Ever since 60 Minutes ran their story on the French Paradox, people are fixated on the idea that red wine can lower your risk of having a heart attack even if everythin...

High-Intensity Exercise Safe and Effective in HCM Patients
https://www.medscape.com/viewarticle/952866

Jun 10th, 2021 - Patients with hypertrophic cardiomyopathy (HCM) can not only safely complete a high-intensity exercise programme but experience significant improvements in fitness, cardiovascular risk, and psychological outcomes, say UK researchers. Dr Joyee Basu...

Pathogenic Variants Tied to Unexplained Sudden Cardiac Death in US Adults
https://www.medscape.com/viewarticle/952606

Jun 8th, 2021 - NEW YORK (Reuters Health) - Close to 20% of U.S. adults dying from unexplained sudden cardiac death (SCD) carried pathogenic or likely pathogenic (P/LP) variants of inherited cardiomyopathies (CMs) and arrhythmia syndromes in a large genetic assoc...

A Farmer With Diffuse Pruritus and a Suntan That Won't Fade
https://reference.medscape.com/viewarticle/952272

Jun 8th, 2021 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy
https://www.medscape.com/viewarticle/952563

Jun 7th, 2021 - Of patients with symptomatic, obstructive hypertrophic cardiomyopathy treated with the investigational oral agent mavacamten, more than twice as many, compared with placebo, had a very large improvement from baseline in their summary quality of li...

see more →

Patient Education  26 results see all →